首页> 外文OA文献 >Implementation and outcomes of a severe acute respiratory coronavirus virus 2 (SARS-CoV-2) monoclonal antibody treatment program at an academic medical center serving a high-risk patient population

【2h】

Implementation and outcomes of a severe acute respiratory coronavirus virus 2 (SARS-CoV-2) monoclonal antibody treatment program at an academic medical center serving a high-risk patient population

机译：在学术医疗中心提供高风险患者人群的严重急性呼吸冠状病毒病毒2（SARS-COV-2）单克隆抗体治疗方案的实施和结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Scott A. Borgetti; Alan E. Gross; Janey Kottler; Kenil Patel; Jamie Paek; Alfredo J. Mena Lora; Diane Oikle; Delisa Jeffries; Jon Radosta;
展开▼
作者单位

展开▼
年度 2021
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Characteristics and Outcomes of 241 Births to Women With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection at Five New York City Medical Centers [J] . Obstetrics and Gynecology: Journal of the American College of Obstetricians and Gynecologists . 2020,第2期

机译：纽约市医疗中心的严重急性呼吸综合征冠状病毒2（SARS-COV-2）感染241名孕妇的特征和结果
2. Convalescent plasma treatment of persistent severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in patients with lymphoma with impaired humoral immunity and lack of neutralising antibodies [J] . Betrains Albrecht, Godinas Laurent, Woei-A-Jin F. J. Sherida H., British Journal of Haematology . 2021,第6期

机译：淋巴瘤患者患有体液免疫障碍患者的持续严重急性呼吸综合征Coronavirus-2（SARS-COV-2）感染的临床血浆治疗患者感染和缺乏中和抗体
3. Seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in patients with cancer and the impact of anti-tumor treatment on antibodies [J] . Bili Wu, Guangyuan Hu, Xianglin Yuan, 中德临床肿瘤学杂志（英文版） . 2021,第003期

机译：癌症患者的严重急性呼吸综合征冠状病毒2（SARS-COV-2）的SEROPREVALING和抗肿瘤治疗对抗体的影响
4. Raising the Specific Antibodies Against the Coronavirus of Severe Acute Respiratory Syndrome [C] . . -1

机译：提高针对严重急性呼吸系统综合症冠状病毒的特异性抗体
5. Characterization of human neutralizing antibodies against severe acute respiratory syndrome coronavirus. [D] . Coughlin, Melissa Marie. 2008

机译：抗严重急性呼吸综合征冠状病毒的人中和抗体的表征。
6. Seroprevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) antibodies among healthcare workers with differing levels of coronavirus disease 2019 (COVID-19) patient exposure [O] . Benton R. Hunter, Lana Dbeibo, Christopher S. Weaver, -1

机译：医疗急性呼吸冠状病毒病毒2（SARS-COV-2）抗体的SEROPREVALING具有不同水平的冠状病毒疾病2019（Covid-19）患者暴露
7. Clinical Characteristics and Outcomes of First 100 Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-Cov-2) Patients: A Single Center Experience [O] . Kashif Naeem, Vinod Choondal, Mahmoud Hamouri, 2020

机译：前100名重型急性呼吸综合征冠状病毒-2（SARS-COV-2）患者的临床特征和结果：单一中心经验

Implementation and outcomes of a severe acute respiratory coronavirus virus 2 (SARS-CoV-2) monoclonal antibody treatment program at an academic medical center serving a high-risk patient population

著录项

引文网络

相似文献

相关主题

期刊订阅